Treace Medical Concepts, Inc. TMCI Stock Issuance Proceeds
Stock Issuance Proceeds at other companies
Other financials
Where this comes from
Reported directly by Treace Medical Concepts, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.
The official record: Treace Medical Concepts, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Treace Medical Concepts, Inc.'s stock issuance proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Treace Medical Concepts, Inc.'s stock issuance proceeds?
- Treace Medical Concepts, Inc. (TMCI) reported stock issuance proceeds of $91K in Q1 2026.
- How has Treace Medical Concepts, Inc.'s stock issuance proceeds changed year-over-year?
- Treace Medical Concepts, Inc.'s stock issuance proceeds decreased by 23.5% year-over-year, from $119K to $91K.
- What is the long-term trend for Treace Medical Concepts, Inc.'s stock issuance proceeds?
- Over 4 years (2021 to 2025), Treace Medical Concepts, Inc.'s stock issuance proceeds has grown at a -26.1% compound annual growth rate (CAGR), from $1.83M to $546K.
- What does stock issuance proceeds mean?
- Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.